Mr. Ramesh Subrahmanian is Group President International of Stryker Corporationrationsince September 1, 2011. He joins Stryker after twentythree years in the pharmaceutical industry where he held a number of senior level leadership roles at Merck, SanofiAventis and Hoechst Marion Roussel Ltd., most recently as Senior Vice President & President, Asia Pacific for Merck & Co. Inc. In his new role, he will have responsibilities for the Company international business units and will be based in Singapore.
Group President - International
Age: 50 President Since 2011
The company has Return on Asset of 8.43 % which means that on every $100 spent on asset it made $8.43 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.2 % implying that it generated $15.2 on every 100 dollars invested.
The company has 2.77 B in debt with debt to equity (D/E) ratio of 0.33 which is OK given its current industry classification. Stryker Corporation has Current Ratio of 4.57 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Entity SummaryStryker Corporationration, a medical technology company, offer reconstructive, medical and surgical, and neurotechnology and spine solutions for doctors, hospitals, and other healthcare facilities. Stryker Corporation [SYK] is traded on New York Stock Exchange in USA. It is located in Kalamazoo, MI and employs 22,010 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| SYK NYSE
Stryker Corporation has less than 12.5 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Stryker price boundaries
Promote Stryker and Ramesh Subrahmanian